Clinical characteristics, prognostic factors and multidrug-resistance related protein expression in 36 adult patients with acute promyelocytic leukemia
- 12 June 2003
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 71 (1) , 1-8
- https://doi.org/10.1034/j.1600-0609.2003.00084.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-upBlood, 2002
- Experience with gemtuzumab ozogamycin (“mylotarg”) and all-trans retinoic acid in untreated acute promyelocytic leukemiaBlood, 2002
- Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experienceBlood, 2002
- Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiersLeukemia, 2002
- The Role of Drug Efflux Pumps in Acute Myeloid LeukemiaLeukemia & Lymphoma, 2002
- All-trans Retinoic Acid (ATRA) Differentiates Acute Promyelocytic Leukemia Cells Independently of P-Glycoprotein (P-gp) Related Multidrug ResistanceLeukemia & Lymphoma, 2001
- All-trans-Retinoic Acid in Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1997
- P‐glycoprotein (PGP) and lung resistance‐related protein (LRP) expression and function in leukaemic blast cellsBritish Journal of Haematology, 1997
- Diagnosis of acute promyelocytic leukaemia by RT‐PCR: detection of PML‐RARA and RARA‐PML fusion transcriptsBritish Journal of Haematology, 1992
- Acute promyelocytic leukemiaThe American Journal of Medicine, 1986